- President Donald Trump and Vice President Mike Pence had been major supporters of the “right-to-try” legislation, which would bypass drug regulators to give gravely ill patients access to experimental medicines.
- Proponents say this gives patients hope they would not otherwise have.
- Critics say the legislation undermines the FDA’s authority to regulate drugs and could leave patients vulnerable to medicines that might not work or may even be harmful.
Could Washington Pick A Side In Sudan’s Civil War?
It must be said at the outset that what follows is necessarily speculative. There is no evidence that Washington has decided to back Sudan’s Rapid Support Forces (RSF), much less that such a policy shift is imminent. But enough developments involving the RSF, the...
